Exact Sciences Corp. (NASDAQ: EXAS) Starts Presentation at 29th Annual ROTH Conference
Exact Sciences (NASDAQ: EXAS) is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer. Exact Sciences’ Cologuard a noninvasive screening test for colorectal cancer that analyzes both stool DNA and blood biomarkers. Cologuard, which is available through healthcare providers, offers people 50 and older at average risk for colorectal cancer an easy-to-use screening test they can do in the privacy of their own home. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. For more information, visit the company’s website at www.exactsciences.com. About NetworkNewsWire…